06:35 AM EDT, 08/06/2025 (MT Newswires) -- BeOne Medicines ( ONC ) reported Q2 adjusted earnings Wednesday of $2.25 per ADS, up from $0.22 a year earlier.

No comparable FactSet estimate was available.

Revenue for the quarter ended June 30 was $1.32 billion, up from $929.2 million a year earlier.

Analysts polled by FactSet expected $1.24 billion.

The company now expects 2025 total revenue of $5.0 billion to $5.3 billion, compared with its prior outlook of $4.9 billion to $5.3 billion. Analysts surveyed by FactSet expect $5.13 billion.

BeOne Medicines ( ONC ) shares were up about 4.5% in recent pre-market activity.